DIN 02468050 — APO-GEFITINIB 250 MG
APO-GEFITINIB is a tablet of Gefitinib marketed by APOTEX INC. The full Gefitinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02468050
- Brand name
- APO-GEFITINIB
- Active ingredient
- Gefitinib
- Strength
- 250 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Gefitinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02248676 | IRESSA | 250 MG | TABLET | ASTRAZENECA CANADA INC | MARKETED |
| 02500663 | JAMP GEFITINIB | 250 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02491796 | NAT-GEFITINIB | 250 MG | TABLET | NATCO PHARMA (CANADA) INC | DORMANT |